Type:

Anaphylaxis UK secures Innovate UK grant to develop support for allergy-related anxiety 28th February 2025

We are delighted to announce that Anaphylaxis UK has been successful in its application to Innovate UK for funding to set up a Knowledge Transfer Partnership (KTP) with the University of Surrey to offer support that addresses the psychological impact of living with serious allergies.

Read more
New study explores peanut allergy treatment for children with higher tolerance levels 20th February 2025

A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with a high-threshold peanut allergy increase their tolerance to

Read more
Research opportunity: have you had a severe food allergy since childhood that requires use of an adrenaline auto-injector? 14th February 2025

The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their

Read more
Managing house dust mite allergy: treatment option now available on the NHS  12th February 2025

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat

Read more
Needle-free nasal adrenaline treatment under review for approval in Canada and the UK 7th February 2025

ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in

Read more
Peanut allergy patch shows promising long-term results in 3-year study 5th February 2025

A recent announcement from DBV Technologies revealed promising long-term results from its EPITOPE Study. Results from a 3-year study showed that the VIASKIN® Peanut patch can help children with peanut allergies become less sensitive to peanuts, reducing the risk of

Read more
Call for participants: help improve safety and support for those living with food allergies 4th February 2025

A group of health care professionals and patient representatives have created a Task Force on Food Allergen Ingestion Risk (‘FAIR’) within the European Academy of Allergy and Clinical Immunology (EAACI). This team is working to explore the challenges and needs

Read more
2024 allergy research & healthcare news roundup: key highlights and breakthroughs 30th January 2025

Living with allergies can sometimes feel isolating, especially when it seems like no one fully understands your struggles or when progress toward better solutions feels slow. However, it’s essential to look toward research to see the great strides being made

Read more
Tracking food allergy trends: a comparison of two UK groups born 12 years apart 30th January 2025

A recent study published in Clinical and Experimental Allergy looked at how food allergies have changed over time by comparing two groups of children from the Isle of Wight—one born in 1989-1990 and the other in 2001-2002. This study explores

Read more